-
1
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ(PPAR γ)
-
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ(PPAR γ). J Biol Chem 270:12953-12956
-
(1995)
J Biol Chem
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
2
-
-
59149084957
-
Peroxisome proliferator-activated receptor γ agonists as insulin sensitizers: From the discovery to recent progress
-
Cho N, Momose Y 2008 Peroxisome proliferator-activated receptor γ agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem 8:1483-1507
-
(2008)
Curr Top Med Chem
, vol.8
, pp. 1483-1507
-
-
Cho, N.1
Momose, Y.2
-
3
-
-
0030297919
-
Adipogenesis and obesity: Rounding out the big picture
-
Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
-
(1996)
Cell
, vol.87
, pp. 377-389
-
-
Spiegelman, B.M.1
Flier, J.S.2
-
4
-
-
0036310015
-
Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells
-
Kim HI, Cha JY, Kim SY, Kim JW, Roh KJ, Seong JK, Lee NT, Choi KY, Kim KS, Ahn YH 2002 Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells. Diabetes 51:676-685
-
(2002)
Diabetes
, vol.51
, pp. 676-685
-
-
Kim, H.I.1
Cha, J.Y.2
Kim, S.Y.3
Kim, J.W.4
Roh, K.J.5
Seong, J.K.6
Lee, N.T.7
Choi, K.Y.8
Kim, K.S.9
Ahn, Y.H.10
-
5
-
-
57749098781
-
In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor γ response element in the mouse pdx-1 promoter
-
Gupta D, Jetton TL, Mortensen RM, Duan SZ, Peshavaria M, Leahy JL 2008 In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor γ response element in the mouse pdx-1 promoter. J Biol Chem 283:32462-32470
-
(2008)
J Biol Chem
, vol.283
, pp. 32462-32470
-
-
Gupta, D.1
Jetton, T.L.2
Mortensen, R.M.3
Duan, S.Z.4
Peshavaria, M.5
Leahy, J.L.6
-
6
-
-
0031847401
-
Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats
-
Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC, Clapham JC 1998 Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47:1326-1334
-
(1998)
Diabetes
, vol.47
, pp. 1326-1334
-
-
Buckingham, R.E.1
Al-Barazanji, K.A.2
Toseland, C.D.3
Slaughter, M.4
Connor, S.C.5
West, A.6
Bond, B.7
Turner, N.C.8
Clapham, J.C.9
-
7
-
-
12144290529
-
Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: Possible protection of β cells from oxidative stress
-
Ishida H, Takizawa M, Ozawa S, Nakamichi Y, Yamaguchi S, Katsuta H, Tanaka T, Maruyama M, Katahira H, Yoshimoto K, Itagaki E, Nagamatsu S 2004 Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β cells from oxidative stress. Metabolism 53:488-494
-
(2004)
Metabolism
, vol.53
, pp. 488-494
-
-
Ishida, H.1
Takizawa, M.2
Ozawa, S.3
Nakamichi, Y.4
Yamaguchi, S.5
Katsuta, H.6
Tanaka, T.7
Maruyama, M.8
Katahira, H.9
Yoshimoto, K.10
Itagaki, E.11
Nagamatsu, S.12
-
8
-
-
0034520463
-
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat
-
Smith SA, Lister CA, Toseland CD, Buckingham RE 2000 Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Diabetes Obes Metab 2:363-372
-
(2000)
Diabetes Obes Metab
, vol.2
, pp. 363-372
-
-
Smith, S.A.1
Lister, C.A.2
Toseland, C.D.3
Buckingham, R.E.4
-
9
-
-
64649092274
-
Peroxisome proliferator-activated receptor γ activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure
-
Evans-Molina C, Robbins RD, Kono T, Tersey SA, Vestermark GL, Nunemaker CS, Garmey JC, Deering TG, Keller SR, Maier B, Mirmira RG 2009 Peroxisome proliferator-activated receptor γ activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol 29:2053-2067
-
(2009)
Mol Cell Biol
, vol.29
, pp. 2053-2067
-
-
Evans-Molina, C.1
Robbins, R.D.2
Kono, T.3
Tersey, S.A.4
Vestermark, G.L.5
Nunemaker, C.S.6
Garmey, J.C.7
Deering, T.G.8
Keller, S.R.9
Maier, B.10
Mirmira, R.G.11
-
10
-
-
74949113575
-
Molecular mechanism by which pioglitazone preserves pancreatic β cells in obese diabetic mice: Evidence for acute and chronic actions as a PPARγ agonist
-
Kanda Y, Shimoda M, Hamamoto S, Tawaramoto K, Kawasaki F, Hashiramoto M, Nakashima K, Matsuki M, Kaku K 2010 Molecular mechanism by which pioglitazone preserves pancreatic β cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist. Am J Physiol Endocrinol Metab 298:E278-E286
-
(2010)
Am J Physiol Endocrinol Metab
, vol.298
-
-
Kanda, Y.1
Shimoda, M.2
Hamamoto, S.3
Tawaramoto, K.4
Kawasaki, F.5
Hashiramoto, M.6
Nakashima, K.7
Matsuki, M.8
Kaku, K.9
-
11
-
-
33947149143
-
β-Cell preservation with thiazolidinediones
-
Campbell IW, Mariz S 2007 β-Cell preservation with thiazolidinediones. Diabetes Res Clin Pract 76:163-176
-
(2007)
Diabetes Res Clin Pract
, vol.76
, pp. 163-176
-
-
Campbell, I.W.1
Mariz, S.2
-
12
-
-
37549055777
-
PPARγ-dependent and -independent effects of rosiglitazone on lipotoxic human pancreatic islets
-
Vandewalle B, Moerman E, Lefebvre B, Defrance F, Gmyr V, Lukowiak B, Kerr Conte J, Pattou F 2008 PPARγ-dependent and -independent effects of rosiglitazone on lipotoxic human pancreatic islets. Biochem Biophys Res Commun 366:1096-1101
-
(2008)
Biochem Biophys Res Commun
, vol.366
, pp. 1096-1101
-
-
Vandewalle, B.1
Moerman, E.2
Lefebvre, B.3
Defrance, F.4
Gmyr, V.5
Lukowiak, B.6
Kerr Conte, J.7
Pattou, F.8
-
13
-
-
33847065108
-
Peroxisome proliferator-activated receptor-γ regulates expression of PDX-1 and NKX6.1 in INS-1 cells
-
Moibi JA, Gupta D, Jetton TL, Peshavaria M, Desai R, Leahy JL 2007 Peroxisome proliferator-activated receptor-γ regulates expression of PDX-1 and NKX6.1 in INS-1 cells. Diabetes 56:88-95
-
(2007)
Diabetes
, vol.56
, pp. 88-95
-
-
Moibi, J.A.1
Gupta, D.2
Jetton, T.L.3
Peshavaria, M.4
Desai, R.5
Leahy, J.L.6
-
14
-
-
77953177935
-
Physiologic and pharmacologic modulation of GIP receptor expression in β-cells by PPARγ signaling: Possible mechanism for the GIP resistance in type 2 diabetes
-
Gupta D, Peshavaria M, Monga N, Jetton TL, Leahy JL 2010 Physiologic and pharmacologic modulation of GIP receptor expression in β-cells by PPARγ signaling: possible mechanism for the GIP resistance in type 2 diabetes. Diabetes 59:1445-1450
-
(2010)
Diabetes
, vol.59
, pp. 1445-1450
-
-
Gupta, D.1
Peshavaria, M.2
Monga, N.3
Jetton, T.L.4
Leahy, J.L.5
-
15
-
-
0033864402
-
Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter
-
Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH 2000 Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 49:1517-1524
-
(2000)
Diabetes
, vol.49
, pp. 1517-1524
-
-
Kim, H.I.1
Kim, J.W.2
Kim, S.H.3
Cha, J.Y.4
Kim, K.S.5
Ahn, Y.H.6
-
16
-
-
0036535976
-
Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity
-
Cnop M, Hannaert JC, Pipeleers DG 2002 Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity. Biochem Pharmacol 63:1281-1285
-
(2002)
Biochem Pharmacol
, vol.63
, pp. 1281-1285
-
-
Cnop, M.1
Hannaert, J.C.2
Pipeleers, D.G.3
-
17
-
-
4143051266
-
Expression and functional activity of PPARγ in pancreatic β cells
-
Welters HJ, McBain SC, Tadayyon M, Scarpello JH, Smith SA, Morgan NG 2004 Expression and functional activity of PPARγ in pancreatic β cells. Br J Pharmacol 142:1162-1170
-
(2004)
Br J Pharmacol
, vol.142
, pp. 1162-1170
-
-
Welters, H.J.1
McBain, S.C.2
Tadayyon, M.3
Scarpello, J.H.4
Smith, S.A.5
Morgan, N.G.6
-
18
-
-
0038772154
-
PPAR-γ overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells
-
Nakamichi Y, Kikuta T, Ito E, Ohara-Imaizumi M, Nishiwaki C, Ishida H, Nagamatsu S 2003 PPAR-γ overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells. Biochem Biophys Res Commun 306:832-836
-
(2003)
Biochem Biophys Res Commun
, vol.306
, pp. 832-836
-
-
Nakamichi, Y.1
Kikuta, T.2
Ito, E.3
Ohara-Imaizumi, M.4
Nishiwaki, C.5
Ishida, H.6
Nagamatsu, S.7
-
19
-
-
23044478417
-
Peroxisome proliferator-activated receptor α (PPARα) potentiates, whereas PPARγ attenuates, glucose-stimulated insulin secretion in pancreatic β-cells
-
Ravnskjaer K, Boergesen M, Rubi B, Larsen JK, Nielsen T, Fridriksson J, Maechler P, Mandrup S 2005 Peroxisome proliferator-activated receptor α (PPARα) potentiates, whereas PPARγ attenuates, glucose-stimulated insulin secretion in pancreatic β-cells. Endocrinology 146:3266-3276
-
(2005)
Endocrinology
, vol.146
, pp. 3266-3276
-
-
Ravnskjaer, K.1
Boergesen, M.2
Rubi, B.3
Larsen, J.K.4
Nielsen, T.5
Fridriksson, J.6
Maechler, P.7
Mandrup, S.8
-
20
-
-
70349423273
-
Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs
-
Schinner S, Krätzner R, Baun D, Dickel C, Blume R, Oetjen E 2009 Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs. Br J Pharmacol 157:736-745
-
(2009)
Br J Pharmacol
, vol.157
, pp. 736-745
-
-
Schinner, S.1
Krätzner, R.2
Baun, D.3
Dickel, C.4
Blume, R.5
Oetjen, E.6
-
21
-
-
0141450254
-
Targeted elimination of peroxisome proliferator-activated receptor γ in β cells leads to abnormalities in islet mass without compromising glucose homeostasis
-
Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu CH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM 2003 Targeted elimination of peroxisome proliferator-activated receptor γ in β cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol 23:7222-7229
-
(2003)
Mol Cell Biol
, vol.23
, pp. 7222-7229
-
-
Rosen, E.D.1
Kulkarni, R.N.2
Sarraf, P.3
Ozcan, U.4
Okada, T.5
Hsu, C.H.6
Eisenman, D.7
Magnuson, M.A.8
Gonzalez, F.J.9
Kahn, C.R.10
Spiegelman, B.M.11
-
22
-
-
23244467098
-
Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase
-
Zhang H, Fujitani Y, Wright CV, Gannon M 2005 Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase. Genesis 42:210-217
-
(2005)
Genesis
, vol.42
, pp. 210-217
-
-
Zhang, H.1
Fujitani, Y.2
Wright, C.V.3
Gannon, M.4
-
23
-
-
0036578921
-
β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass
-
Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR 2002 β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115
-
(2002)
Nat Genet
, vol.31
, pp. 111-115
-
-
Kulkarni, R.N.1
Holzenberger, M.2
Shih, D.Q.3
Ozcan, U.4
Stoffel, M.5
Magnuson, M.A.6
Kahn, C.R.7
-
24
-
-
2642653233
-
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice
-
Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR 1997 Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736
-
(1997)
J Clin Invest
, vol.100
, pp. 2729-2736
-
-
Kulkarni, R.N.1
Wang, Z.L.2
Wang, R.M.3
Hurley, J.D.4
Smith, D.M.5
Ghatei, M.A.6
Withers, D.J.7
Gardiner, J.V.8
Bailey, C.J.9
Bloom, S.R.10
-
25
-
-
51349103007
-
MafA is a dedicated activator of the insulin gene in vivo
-
Artner I, Hang Y, Guo M, Gu G, Stein R 2008 MafA is a dedicated activator of the insulin gene in vivo. J Endocrinol 198:271-279
-
(2008)
J Endocrinol
, vol.198
, pp. 271-279
-
-
Artner, I.1
Hang, Y.2
Guo, M.3
Gu, G.4
Stein, R.5
-
26
-
-
33646194560
-
A switch from MafB to MafA expression accompanies differentiation to pancreatic β-cells
-
Nishimura W, Kondo T, Salameh T, El Khattabi I, Dodge R, Bonner-Weir S, Sharma A 2006 A switch from MafB to MafA expression accompanies differentiation to pancreatic β-cells. Dev Biol 293:526-539
-
(2006)
Dev Biol
, vol.293
, pp. 526-539
-
-
Nishimura, W.1
Kondo, T.2
Salameh, T.3
El Khattabi, I.4
Dodge, R.5
Bonner-Weir, S.6
Sharma, A.7
-
27
-
-
33847722655
-
β-Cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment
-
Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR 2007 β-Cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13:340-347
-
(2007)
Nat Med
, vol.13
, pp. 340-347
-
-
Brunham, L.R.1
Kruit, J.K.2
Pape, T.D.3
Timmins, J.M.4
Reuwer, A.Q.5
Vasanji, Z.6
Marsh, B.J.7
Rodrigues, B.8
Johnson, J.D.9
Parks, J.S.10
Verchere, C.B.11
Hayden, M.R.12
-
28
-
-
77952406884
-
Carriers of loss-of-function mutations in ABCA1 display pancreatic β-cell dysfunction
-
Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, Kastelein JJ, Hayden MR, Stroes ES 2010 Carriers of loss-of-function mutations in ABCA1 display pancreatic β-cell dysfunction. Diabetes Care 33:869-874
-
(2010)
Diabetes Care
, vol.33
, pp. 869-874
-
-
Vergeer, M.1
Brunham, L.R.2
Koetsveld, J.3
Kruit, J.K.4
Verchere, C.B.5
Kastelein, J.J.6
Hayden, M.R.7
Stroes, E.S.8
-
29
-
-
0035138625
-
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
-
Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B 2001 PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58
-
(2001)
Nat Med
, vol.7
, pp. 53-58
-
-
Chinetti, G.1
Lestavel, S.2
Bocher, V.3
Remaley, A.T.4
Neve, B.5
Torra, I.P.6
Teissier, E.7
Minnich, A.8
Jaye, M.9
Duverger, N.10
Brewer, H.B.11
Fruchart, J.C.12
Clavey, V.13
Staels, B.14
-
30
-
-
9444296497
-
Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic β-cells
-
Efanov AM, Sewing S, Bokvist K, Gromada J 2004 Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic β-cells. Diabetes 53(Suppl 3):S75-S78
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Efanov, A.M.1
Sewing, S.2
Bokvist, K.3
Gromada, J.4
-
31
-
-
77949316652
-
Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling
-
Ogihara T, Chuang JC, Vestermark GL, Garmey JC, Ketchum RJ, Huang X, Brayman KL, Thorner MO, Repa JJ, Mirmira RG, Evans-Molina C 2010 Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 285:5392-5404
-
(2010)
J Biol Chem
, vol.285
, pp. 5392-5404
-
-
Ogihara, T.1
Chuang, J.C.2
Vestermark, G.L.3
Garmey, J.C.4
Ketchum, R.J.5
Huang, X.6
Brayman, K.L.7
Thorner, M.O.8
Repa, J.J.9
Mirmira, R.G.10
Evans-Molina, C.11
-
32
-
-
57249094223
-
Activation of liver X receptors inhibits pancreatic islet β cell proliferation through cell cycle arrest
-
Meng ZX, Nie J, Ling JJ, Sun JX, Zhu YX, Gao L, Lv JH, Zhu DY, Sun YJ, Han X 2009 Activation of liver X receptors inhibits pancreatic islet β cell proliferation through cell cycle arrest. Diabetologia 52:125-135
-
(2009)
Diabetologia
, vol.52
, pp. 125-135
-
-
Meng, Z.X.1
Nie, J.2
Ling, J.J.3
Sun, J.X.4
Zhu, Y.X.5
Gao, L.6
Lv, J.H.7
Zhu, D.Y.8
Sun, Y.J.9
Han, X.10
-
33
-
-
25844454854
-
Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis
-
Busch AK, Gurisik E, Cordery DV, Sudlow M, Denyer GS, Laybutt DR, Hughes WE, Biden TJ 2005 Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 54:2917-2924
-
(2005)
Diabetes
, vol.54
, pp. 2917-2924
-
-
Busch, A.K.1
Gurisik, E.2
Cordery, D.V.3
Sudlow, M.4
Denyer, G.S.5
Laybutt, D.R.6
Hughes, W.E.7
Biden, T.J.8
-
34
-
-
3042781392
-
Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1
-
Peyot ML, Nolan CJ, Soni K, Joly E, Lussier R, Corkey BE, Wang SP, Mitchell GA, Prentki M 2004 Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1. Diabetes 53:1733-1742
-
(2004)
Diabetes
, vol.53
, pp. 1733-1742
-
-
Peyot, M.L.1
Nolan, C.J.2
Soni, K.3
Joly, E.4
Lussier, R.5
Corkey, B.E.6
Wang, S.P.7
Mitchell, G.A.8
Prentki, M.9
-
35
-
-
58149350345
-
Postnatal expansion of the pancreatic β-cell mass is dependent on survivin
-
Jiang Y, Nishimura W, Devor-Henneman D, Kusewitt D, Wang H, Holloway MP, Dohi T, Sabo E, Robinson ML, Altieri DC, Sharma A, Altura RA 2008 Postnatal expansion of the pancreatic β-cell mass is dependent on survivin. Diabetes 57:2718-2727
-
(2008)
Diabetes
, vol.57
, pp. 2718-2727
-
-
Jiang, Y.1
Nishimura, W.2
Devor-Henneman, D.3
Kusewitt, D.4
Wang, H.5
Holloway, M.P.6
Dohi, T.7
Sabo, E.8
Robinson, M.L.9
Altieri, D.C.10
Sharma, A.11
Altura, R.A.12
-
36
-
-
7044260753
-
Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-γ-deficient mice on a high-fat diet
-
Matsui J, Terauchi Y, Kubota N, Takamoto I, Eto K, Yamashita T, Komeda K, Yamauchi T, Kamon J, Kita S, Noda M, Kadowaki T 2004 Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-γ-deficient mice on a high-fat diet. Diabetes 53:2844-2854
-
(2004)
Diabetes
, vol.53
, pp. 2844-2854
-
-
Matsui, J.1
Terauchi, Y.2
Kubota, N.3
Takamoto, I.4
Eto, K.5
Yamashita, T.6
Komeda, K.7
Yamauchi, T.8
Kamon, J.9
Kita, S.10
Noda, M.11
Kadowaki, T.12
|